Callan Family Office’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.95M | Buy |
89,738
+63,300
| +239% | +$7.02M | 0.31% | 60 |
|
|
2025
Q1 | $2.96M | Sell |
26,438
-4,149
| -14% | -$465K | 0.22% | 100 |
|
|
2024
Q4 | $2.83M | Buy |
+30,587
| New | +$2.83M | 0.18% | 113 |
|
|
2023
Q2 | – | Sell |
-13,778
| Closed | -$1.14M | – | 131 |
|
|
2023
Q1 | $1.14M | Buy |
+13,778
| New | +$1.14M | 0.28% | 54 |
|